Compare Mesoblast Limited (MESO) vs MakeMyTrip Ltd (MMYT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs MakeMyTrip Ltd — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while MakeMyTrip Ltd trades at $56.43 (market cap $5.05B). The key difference: MakeMyTrip Ltd is far larger — about 2.3× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, MakeMyTrip Ltd nearer its low. Which is the better fit depends on your goals.
| MESO | MMYT | |
|---|---|---|
Market Cap | $2.17B | $5.05B |
Sector | Technology | Technology |
52-Week High | $20.96 | $103.21 |
52-Week Low | $12.88 | $36.30 |
Enterprise Value | $2.17B | $5.69B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About MakeMyTrip Ltd
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →
